Can GPR4 Be a Potential Therapeutic Target for COVID-19?

Thumbnail
View/ Open

Show full item record

Author
Yang, Li V.; Oppelt, Karen A.; Thomassen, Mary Jane; Marie, Mona A.; Nik Akhtar, Shayan; McCallen, Justin D.
URI
http://hdl.handle.net/10342/10983
Subject
 COVID-19; inflammation; endothelial cell 
Date
2021-01-21
Citation:
APA:
Yang, Li V., & Oppelt, Karen A., & Thomassen, Mary Jane, & Marie, Mona A., & Nik Akhtar, Shayan, & McCallen, Justin D.. (January 2021). Can GPR4 Be a Potential Therapeutic Target for COVID-19?. Frontiers in Medicine, (. Retrieved from http://hdl.handle.net/10342/10983

Display/Hide MLA, Chicago and APA citation formats.

MLA:
Yang, Li V., and Oppelt, Karen A., and Thomassen, Mary Jane, and Marie, Mona A., and Nik Akhtar, Shayan, and McCallen, Justin D.. "Can GPR4 Be a Potential Therapeutic Target for COVID-19?". Frontiers in Medicine. . (.), January 2021. September 26, 2022. http://hdl.handle.net/10342/10983.
Chicago:
Yang, Li V. and Oppelt, Karen A. and Thomassen, Mary Jane and Marie, Mona A. and Nik Akhtar, Shayan and McCallen, Justin D., "Can GPR4 Be a Potential Therapeutic Target for COVID-19?," Frontiers in Medicine 7, no. (January 2021), http://hdl.handle.net/10342/10983 (accessed September 26, 2022).
AMA:
Yang, Li V., Oppelt, Karen A., Thomassen, Mary Jane, Marie, Mona A., Nik Akhtar, Shayan, McCallen, Justin D.. Can GPR4 Be a Potential Therapeutic Target for COVID-19?. Frontiers in Medicine. January 2021; 7() . http://hdl.handle.net/10342/10983. Accessed September 26, 2022.
Collections